You can find a current list of all my publications here
2020
Tessier-Cloutier, B, D. R. Cochrane, A. N. Karnezis, S. Colborne, J. Magrill, A. Talhouk, J. Zhang, S. Leung, C. S. Hughes, A. Piskorz, A. S. Cheng, K. Greening, A. du Bois, J. Pfisterer, R. A. Soslow, S. Kommoss, J. D. Brenton, G. B. Morin, C. B. Gilks, D. G. Huntsman, et al. (2020). “Proteomic Analysis of Transitional Cell Carcinoma-Like Variant of Tubo-Ovarian High-Grade Serous Carcinoma”. In: Human Pathology.
Llaurado Fernandez, M, A. Dawson, H. Kim, N. Lam, H. Russell, M. Bruce, M. Bittner, J. Hoenisch, S. A. Scott, A. Talhouk, D. Chiu, D. Provencher, M. Nourmoussavi, G. DiMattia, C. Lee, C. B. Gilks, M. Köbel and M. S. Carey (2020). “Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma”. In: Gynecologic Oncology.
Kommoss, F. K. F, D. Stichel, D. Schrimpf, M. Kriegsmann, B. Tessier-Cloutier, A. Talhouk, J. N. McAlpine, K. T. E. Chang, D. Sturm, S. M. Pfister, L. Romero-Pérez, T. Kirchner, T. G. P. Grünewald, R. Buslei, H. Sinn, G. Mechtersheimer, P. Schirmacher, D. Schmidt, H. Lehr, F. Sahm, et al. (2020). “DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics”. In: Journal of Cancer Research and Clinical Oncology 146.1, pp. 97-104.
Talhouk, A, J. George, C. Wang, T. Budden, T. Z. Tan, D. S. Chiu, S. Kommoss, H. S. Leong, S. Chen, M. P. Intermaggio, B. Gilks, T. M. Nazeran, M. Volchek, W. Elatre, R. C. Bentley, J. Senz, A. Lum, V. Chow, H. Sudderuddin, R. Mackenzie, et al. (2020). “Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)”. In: Clinical Cancer Research, p. clincanres.0103.2020.
Millstein, J, T. Budden, E. Goode, M. Anglesio, A. Talhouk, M. Intermaggio, H. Leong, S. Chen, W. Elatre, B. Gilks, T. Nazeran, M. Volchek, R. Bentley, C. Wang, D. Chiu, S. Kommoss, S. Leung, J. Senz, A. Lum, V. Chow, et al. (2020). “Prognostic gene expression signature for high-grade serous ovarian cancer”. In: Annals of Oncology.
Martins, F. C, D. Couturier, A. Paterson, A. N. Karnezis, C. Chow, T. M. Nazeran, A. Odunsi, A. Gentry-Maharaj, A. Vrvilo, A. Hein, A. Talhouk, A. Osorio, A. D. Hartkopf, A. Brooks-Wilson, A. DeFazio, A. Fischer, A. Hartmann, B. Y. Hernandez, B. M. McCauley, C. Karpinskyj, et al. (2020). “Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium”. In: British Journal of Cancer, pp. 1-10.
2019
Arora, N, A. Talhouk, J. N. McAlpine, M. R. Law and G. E. Hanley (2019). “Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada”. In: International Journal of Gynecologic Cancer 29.3, pp. 593-598.
Bodelon, C, J. K. Killian, J. N. Sampson, W. F. Anderson, R. Matsuno, L. A. Brinton, J. Lissowska, M. S. Anglesio, D. D. L. Bowtell, J. A. Doherty, S. J. Ramus, A. Talhouk, M. Sherman and N. Wentzensen (2019). “Molecular classification of epithelial ovarian cancer based on methylation profiling: evidence for survival heterogeneity.”. In: Clinical cancer research : an official journal of the American Association for Cancer Research, p. clincanres.3720.2018.
Britton, H, L. Huang, A. Lum, S. Leung, K. Shum, M. Kale, A. Burleigh, J. Senz, W. Yang, M. McConechy, S. Kommoss, S. Brucker, A. Talhouk, C. B. Gilks and J. N. McAlpine (2019). “Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma”. In: Gynecologic Oncology 153.3, pp. 487-495.
Escala-Garcia, M, Q. Guo, T. Dörk, S. Canisius, R. Keeman, J. Dennis, J. Beesley, J. Lecarpentier, M. K. Bolla, Q. Wang, J. Abraham, I. L. Andrulis, H. Anton-Culver, V. Arndt, P. L. Auer, M. W. Beckmann, S. Behrens, J. Benitez, M. Bermisheva, L. Bernstein, et al. (2019). “Genome-wide association study of germline variants and breast cancer-specific mortality”. In: British Journal of Cancer 120.6, pp. 647-657.
Kaurah, P, A. Talhouk, A. MacMillan, I. Lewis, K. Chelcun-Schreiber, S. S. Yoon and D. Huntsman (2019). “Hereditary diffuse gastric cancer: cancer risk and the personal cost of preventive surgery.”. In: Familial cancer 18.4, pp. 429-438.
Meagher, N. S, L. Wang, P. F. Rambau, M. P. Intermaggio, D. G. Huntsman, L. R. Wilkens, M. A. El-Bahrawy, R. B. Ness, K. Odunsi, H. Steed, E. Herpel, M. S. Anglesio, B. Zhang, N. Lambie, A. J. Swerdlow, J. Lubiński, R. A. Vierkant, E. L. Goode, U. Menon, A. Toloczko-Grabarek, et al. (2019). “A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.”. In: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 32.12, pp. 1834-1846.
Talhouk, A, H. Derocher, P. Schmidt, S. Leung, K. Milne, C. B. Gilks, M. S. Anglesio, B. H. Nelson and J. N. McAlpine (2019). “Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma”. In: Clinical Cancer Research 25.8, pp. 2537-2548.
Wang, L, P. F. Rambau, L. E. Kelemen, M. S. Anglesio, S. Leung, A. Talhouk and M. Köbel (2019). “Nuclear β-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome”. In: Histopathology 74.3, pp. 452-462.
2018
Arora, N, A. Talhouk, J. N. McAlpine, M. R. Law and G. E. Hanley (2018). “Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada.”. In: BMC cancer 18.1, p. 1039.
Chiu, D. S. and A. Talhouk (2018). “diceR: an R package for class discovery using an ensemble driven approach”. In: BMC Bioinformatics 19.1, p. 11.
Kommoss, F. K, A. N. Karnezis, F. Kommoss, A. Talhouk, F. Taran, A. Staebler, C. B. Gilks, D. G. Huntsman, B. Krämer, S. Y. Brucker, J. N. McAlpine and S. Kommoss (2018). “L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile”. In: British Journal of Cancer 119.4, pp. 480-486.
Kommoss, S, M. K. McConechy, F. Kommoss, S. Leung, A. Bunz, J. Magrill, H. Britton, F. Kommoss, F. Grevenkamp, A. Karnezis, W. Yang, A. Lum, B. Krämer, F. Taran, A. Staebler, S. Lax, S. Y. Brucker, D. G. Huntsman, C. B. Gilks, J. N. McAlpine, and A. Talhouk. (2018). “Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series”. In: Annals of Oncology 29.5, pp. 1180-1188.
Magrill, J, A. N. Karnezis, B. Tessier-Cloutier, A. Talhouk, S. Kommoss, D. Cochrane, C. Chow, A. Cheng, R. Soslow, S. Hauptmann, A. du Bois, J. Pfisterer, C. B. Gilks, D. G. Huntsman and F. Kommoss (2018). “Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry Profiles”. In: International Journal of Gynecological Pathology, p. 1.
Rambau, P. F, R. A. Vierkant, M. P. Intermaggio, L. E. Kelemen, M. T. Goodman, E. Herpel, P. D. Pharoah, S. Kommoss, M. Jimenez-Linan, B. Y. Karlan, A. Gentry-Maharaj, U. Menon, S. H. Polo, F. J. Candido dos Reis, J. A. Doherty, S. A. Gayther, R. Sharma, M. C. Larson, P. R. Harnett, E. Hatfield, et al. (2018). “Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study”. In: The Journal of Pathology: Clinical Research 4.4, pp. 250-261.
2017
Färkkilä, A, M. K. McConechy, W. Yang, A. Talhouk, Y. Ng, A. Lum, R. D. Morin, K. Bushell, A. Riska, J. N. McAlpine, C. B. Gilks, L. Unkila-Kallio, M. Anttonen and D. G. Huntsman (2017). “FOXL2 402CMutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell Tumor”. In: The Journal of Molecular Diagnostics 19.1, pp. 126-136.
Hoang, L. N, M. A. Kinloch, J. M. Leo, K. Grondin, C. Lee, C. Ewanowich, M. Köbel, A. Cheng, A. Talhouk, M. McConechy, D. G. Huntsman, J. N. McAlpine, R. A. Soslow and C. B. Gilks (2017). “Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup”. In: The American Journal of Surgical Pathology 41.2, pp. 245-252.
Karnezis, A. N, S. Leung, J. Magrill, M. K. McConechy, W. Yang, C. Chow, M. Kobel, C. Lee, D. G. Huntsman, A. Talhouk, F. Kommoss, C. B. Gilks and J. N. McAlpine (2017). “Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification”. In: The Journal of Pathology: Clinical Research 3.4, pp. 279-293.
Lo, C. S, S. Sanii, D. R. Kroeger, K. Milne, A. Talhouk, D. S. Chiu, K. Rahimi, P. A. Shaw, B. A. Clarke and B. H. Nelson (2017). “Neoadjuvant chemotherapy of ovarian cancer results in three patterns of tumor-infiltrating lymphocyte response with distinct implications for immunotherapy”. In: Clinical Cancer Research 23.4, pp. 925-934.
McAlpine, J. N, S. C. Y. Leung, A. Cheng, D. Miller, A. Talhouk, C. B. Gilks and A. N. Karnezis (2017). “Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study”. In: Histopathology 71.2, pp. 238-246.
Proctor, L, M. Pradhan, S. Leung, A. Cheng, C. Lee, R. Soslow, C. Gilks, A. Talhouk, J. McAlpine, H. Danielsen and L. Hoang (2017). “Assessment of DNA Ploidy in the ProMisE molecular subgroups of endometrial cancer”. In: Gynecologic Oncology 146.3, pp. 596-602.
Talhouk, A, M. K. McConechy, S. Leung, W. Yang, A. Lum, J. Senz, N. Boyd, J. Pike, M. Anglesio, J. S. Kwon, A. N. Karnezis, D. G. Huntsman, C. B. Gilks and J. N. McAlpine (2017). “Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer”. In: Cancer123.5, pp. 802-813.
2016
McConechy, M. K, A. Farkkila, H. M. Horlings, A. Talhouk, L. Unkila-Kallio, H. S. Van Meurs, Y. Winnie, N. Rozenberg, N. Andersson, K. Zaby, S. Bryk, R. Butzow, J. B. Halfwerk, G. K. Hooijer, M. J. Van De Vijver, M. R. Buist, G. G. Kenter, S. Y. Brucker, B. Kramer, A. Staebler, et al. (2016). “Molecularly defined adult granulosa cell tumor of the ovary: The clinical phenotype”. In: Journal of the National Cancer Institute 108.11.
McConechy, M. K, A. Talhouk, S. Leung, D. Chiu, W. Yang, J. Senz, L. J. Reha-Krantz, C. H. Lee, D. G. Huntsman, C. B. Gilks and J. N. McAlpine (2016). “Endometrial carcinomas with POLE exonuclease domain mutations have a favorable prognosis”. In: Clinical Cancer Research 22.12, pp. 2865-2873.
Talhouk, A, L. N. Hoang, M. K. McConechy, Q. Nakonechny, J. Leo, A. Cheng, S. Leung, W. Yang, A. Lum, M. Köbel, C. H. Lee, R. A. Soslow, D. G. Huntsman, C. B. Gilks and J. N. McAlpine (2016). “Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment”. In: Gynecologic Oncology 143.1, pp. 46-53.
Talhouk, A, S. Kommoss, R. Mackenzie, M. Cheung, S. Leung, D. S. Chiu, S. E. Kalloger, D. G. Huntsman, S. Chen, M. Intermaggio, J. Gronwald, F. C. Chan, S. J. Ramus, C. Steidl, D. W. Scott and M. S. Anglesio (2016). “Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect Correction”. In: PLOS ONE 11.4. Ed. by B. Haibe-Kains, p. e0153844.
Talhouk, A. and J. N. McAlpine (2016). “New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care.”. In: Gynecologic oncology research and practice 3.1, p. 14.
2015
Burleigh, A, A. Talhouk, C. B. Gilks and J. N. McAlpine (2015). “Clinical and pathological characterization of endometrial cancer in young women: Identification of a cohort without classical risk factors”. In: Gynecologic Oncology 138.1, pp. 141-146.
Hansford, S, P. Kaurah, H. Li-Chang, M. Woo, J. Senz, H. Pinheiro, K. A. Schrader, D. F. Schaeffer, K. Shumansky, G. Zogopoulos, T. A. Santos, I. Claro, J. Carvalho, C. Nielsen, S. Padilla, A. Lum, A. Talhouk, K. Baker-Lange, S. Richardson, I. Lewis, et al. (2015). “Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.”. In: JAMA oncology 1.1, pp. 23-32.
Mackenzie, R, A. Talhouk, S. Eshragh, S. Lau, D. Cheung, C. Chow, N. Le, L. S. Cook, N. Wilkinson, J. McDermott, N. Singh, F. Kommoss, J. Pfisterer, D. G. Huntsman, M. Köbel, S. Kommoss, C. B. Gilks and M. S. Anglesio (2015). “Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.”. In: The American journal of surgical pathology 39.11, pp. 1548-57.
McConechy, M, A. Talhouk, H. Li-Chang, S. Leung, D. Huntsman, C. Gilks and J. McAlpine (2015). “Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas”. In: Gynecologic Oncology 137.2, pp. 1-5.
Talhouk, A, M. K. McConechy, S. Leung, H. H. Li-Chang, J. S. Kwon, N. Melnyk, W. Yang, J. Senz, N. Boyd, A. N. Karnezis, D. G. Huntsman, C. B. Gilks and J. N. McAlpine (2015). “A clinically applicable molecular-based classification for endometrial cancers.”. In: British journal of cancer113.2, pp. 299-310.
2012
Talhouk, A, A. Doucet and K. Murphy (2012). “Efficient Bayesian Inference for Multivariate Probit Models With Sparse Inverse Correlation Matrices”. In: Journal of Computational and Graphical Statistics 21.3, pp. 739-757.
2010
Garmaroudi, F. S, D. Marchant, X. Si, A. Khalili, A. Bashashati, B. W. Wong, A. Tabet, R. T. Ng, K. Murphy, H. Luo, K. A. Janes and B. M. McManus (2010). “Pairwise network mechanisms in the host signaling response to coxsackievirus B3 infection.”. In: Proceedings of the National Academy of Sciences of the United States of America 107, pp. 17053-17058.
Illes, J, K. Tairyan, C. A. Federico, A. Talhouk-Tabet and G. H. Glover (2010). “Reducing barriers to ethics in neuroscience.”. In: Frontiers in human neuroscience 4.